Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : BIAF save search
bioAffinity Technologies Publishes Peer-Reviewed Results of High-Throughput Flow Cytometry Use for Evaluating Lung Health in PLOS ONE
Published: 2022-09-14 (Crawled : 13:00) - biospace.com/
BIAF | $2.79 -4.12% -4.68% 140K
|
|
| O: 37.68%
H: 19.3%
C: -14.74%
lung health flow one
bioAffinity Technologies Presents Results from Flow Cytometry Analysis of the Lung at CHEST Conference
Published: 2022-10-12 (Crawled : 13:00) - biospace.com/
BIAF | $2.79 -4.12% -4.68% 140K
|
|
| O: 0.0%
H: 2.68%
C: -0.36%
lung conference flow results
bioAffinity Technologies Receives Additional $7.7M from Exercise of Warrants, Total Capital from Public Offering Increases to Approximately $15.6M
Published: 2022-09-28 (Crawled : 12:20) - feed.businesswire.com
BIAF | $2.79 -4.12% -4.68% 140K
|
|
| O: 69.81%
H: 17.5%
C: -18.89%
offering
bioAffinity Technologies Announces Sheila Habib, MD and David Hill, MD Join the Company’s Scientific and Medical Advisory Board
Published: 2022-11-10 (Crawled : 15:00) - biospace.com/
BIAF | $2.79 -4.12% -4.68% 140K
|
|
| O: 1.05%
H: 14.52%
C: 6.22%
bioAffinity Technologies to Report Third Quarter 2022 Financial Results
Published: 2022-11-08 (Crawled : 13:20) - biospace.com/
BIAF | $2.79 -4.12% -4.68% 140K
|
|
| O: -0.18%
H: 5.22%
C: -0.96%
report financial results
bioAffinity Technologies Announces Pricing of IPO
Published: 2022-09-01 (Crawled : 12:20) - feed.businesswire.com
BIAF | $2.79 -4.12% -4.68% 140K
|
| Email alert
Add to watchlist
technology
bioAffinity Technologies, Inc. Announces Closing of $7.8 Million Initial Public Offering
Published: 2022-09-06 (Crawled : 16:00) - feed.businesswire.com
BIAF | $2.79 -4.12% -4.68% 140K
|
|
| O: -10.07%
H: 3.94%
C: -14.98%
offering
WallachBeth Capital Announce Pricing Of bioAffinity Technologies IPO At $6.125 Per Unit
Published: 2022-09-01 (Crawled : 17:00) - prnewswire.com
BIAF | $2.79 -4.12% -4.68% 140K
|
| Email alert
Add to watchlist
bioAffinity Technologies Reports Third Quarter 2022 Financial Results and Provides Business Update
Published: 2022-11-14 (Crawled : 13:00) - biospace.com/
BIAF | $2.79 -4.12% -4.68% 140K
|
|
| O: -2.83%
H: 1.82%
C: 0.0%
financial update results
bioAffinity Technologies Presents at Cleveland Clinic Lung Cancer Symposium
Published: 2023-04-25 (Crawled : 13:00) - biospace.com/
BIAF | $2.79 -4.12% -4.68% 140K
|
|
| O: 2.44%
H: 0.0%
C: -2.38%
lung symposium cancer
Argus Research Initiates Equity Research Report Coverage on Largo Inc. (NasdaqGS: LGO, TSX: LGO)
Published: 2023-03-28 (Crawled : 12:00) - prnewswire.com
BIAF | $2.79 -4.12% -4.68% 140K
|
|
| O: 1.76%
H: 2.03%
C: -6.03%
report research
bioAffinity Technologies Announces Publication of Peer-Reviewed Paper on Proprietary Beads Used in CyPath® Lung for Noninvasive Detection of Early-Stage Lung Cancer
Published: 2023-03-28 (Crawled : 13:00) - biospace.com/
BIAF | $2.79 -4.12% -4.68% 140K
|
|
| O: 1.76%
H: 2.03%
C: -6.03%
cypath lung cancer publication
bioAffinity Technologies to Report Fourth Quarter 2022 Financial Results on March 31, 2023
Published: 2023-03-24 (Crawled : 13:00) - biospace.com/
BIAF | $2.79 -4.12% -4.68% 140K
|
|
| O: 5.56%
H: 0.53%
C: -3.68%
report financial results
bioAffinity Technologies Announces Publication of Results of Clinical Trial in Peer-Reviewed Journal Respiratory Research
Published: 2023-01-24 (Crawled : 15:00) - biospace.com/
BIAF | $2.79 -4.12% -4.68% 140K
|
|
| O: 20.13%
H: 108.9%
C: 46.07%
research respiratory trial results publication
bioAffinity Technologies Announces Notice to Award U.S. Patent Protecting Novel Compounds for Specific Delivery of Cancer Treatments
Published: 2023-01-04 (Crawled : 15:00) - biospace.com/
BIAF | $2.79 -4.12% -4.68% 140K
|
|
| O: 14.1%
H: 0.01%
C: -7.3%
award patent cancer
Argus Research Initiates Equity Research Report Coverage on bioAffinity Technologies, Inc. (NasdaqCM: BIAF)
Published: 2022-12-19 (Crawled : 17:00) - prnewswire.com
BIAF | $2.79 -4.12% -4.68% 140K
|
|
| O: 0.0%
H: 5.58%
C: -4.57%
research report
bioAffinity Technologies Presents Proprietary Cancer Therapeutic Research at Joint ASCB-EMBO Meeting
Published: 2022-12-01 (Crawled : 14:00) - biospace.com/
BIAF | $2.79 -4.12% -4.68% 140K
|
|
| O: 1.26%
H: 2.05%
C: 1.32%
research meeting cancer
bioAffinity Technologies Presents Research Findings at CYTO 2023
Published: 2023-05-22 (Crawled : 14:00) - biospace.com/
BIAF | $2.79 -4.12% -4.68% 140K
|
|
| O: 0.0%
H: 3.83%
C: 3.83%
research
bioAffinity Technologies Reports First Quarter 2023 Financial Results
Published: 2023-05-15 (Crawled : 14:00) - biospace.com/
BIAF | $2.79 -4.12% -4.68% 140K
|
|
| O: -5.37%
H: 5.67%
C: 3.96%
financial results
bioAffinity Technologies Names Michael Dougherty as Chief Financial Officer
Published: 2023-05-01 (Crawled : 13:00) - biospace.com/
BIAF | $2.79 -4.12% -4.68% 140K
|
|
| O: -0.51%
H: 7.22%
C: 5.67%
financial
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
INVO | $1.52 100.0% 51.13% 5M
|
Health Technology
ISPC | $0.421 97.65% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.5 45.65% 470K
|
OST | $0.509 23.81% 45.26% 90K
|
GDHG | $0.263 21.76% 40.66% 3.1M
|
XPON | News | $3.15 63.21% 37.74% 16M
|
TIRX | $0.8 65.02% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.